Forte Biosciences FY 2023 Results: GAAP EPS of -$1.00 and Cash Position
Monday, 18 March 2024, 20:42
Forte Biosciences FY 2023 Financial Report
In a recent update, Forte Biosciences disclosed a FY 2023 GAAP EPS of -$1.00 and a cash reserve of $37.1 million. The results shed light on the company's financial health and available resources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.